Doxycycline for STI Prevention: Evidence and Current Research

Friday, October 7, 2022

Very high STI prevalence is being observed globally. Doxycycline post-exposure prophylaxis (dPEP) has been proposed as an STI prevention strategy to reduce chlamydia, syphilis, and possibly gonorrhea, and trials are ongoing among cisgender gay and bisexual men as well as African cisgender women. Learn about the latest scientific data and more during this Choice Agenda webinar.

Featuring Dr. Connie Celum, Jennifer Mahn, Dr. Victor Omollo, Rodney Perkins and Dr. Jenell Stewart

Recording / Slides / Resources

Accelerating Product Innovation